MedPath
HSA Approval

DEXTRACIN EYE/EAR DROPS

SIN00959P

DEXTRACIN EYE/EAR DROPS

DEXTRACIN EYE/EAR DROPS

May 10, 1988

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION

OPHTHALMIC, AURICULAR (OTIC)

Medical Information

S03CA01

dexamethasone and antiinfectives

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

DEXAMETHASONE SODIUM PHOSPHATE EQV DEXAMETHASONE PHOSPHATE

0.1% w/v

Dexamethasone

NEOMYCIN SULPHATE

0.5% w/v

Neomycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DEXTRACIN EYE/EAR DROPS - HSA Approval | MedPath